Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity

Efficacy data of aprocitentan reinforce endothelin pathway blockade as a new therapeutic approach across the cardiometabolic disease spectrum and obesity

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.